Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-05-18
1995-01-31
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483591, A61K 31415, C07D23154
Patent
active
053859286
ABSTRACT:
A series of 1,3,4,5-tetrahydrobenz[c,d]indazoles having activities as regulators of serotonin functions, particularly in the brain.
REFERENCES:
patent: 4576959 (1986-03-01), Flaugh
patent: 4983622 (1991-01-01), Flaugh
patent: 5026869 (1991-06-01), Flaugh
patent: 5039820 (1991-08-01), Kress et al.
patent: 5204340 (1993-04-01), Flaugh et al.
patent: 5212319 (1993-05-01), Kress et al.
patent: 5229409 (1993-07-01), Flaugh et al.
patent: 5229410 (1993-07-01), Flaugh et al.
patent: 5244912 (1993-09-01), Booher et al.
patent: 5302612 (1994-04-01), Flaugh et al.
Ainsworth, The Indazole Analog of Serotonin, 70, 5245-5247 (1957).
Bertaccini, Chemical Abstracts, 56, 6595d (1961).
Kocjan et al "Chemical Abstracts" vol 107 (1987) No. 211, 742j.
Boone David E.
Eli Lilly and Company
Jones Joseph A.
Ramsuer Robert W.
LandOfFree
Tetrahydrobenz [CD] indazoles, compositions and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydrobenz [CD] indazoles, compositions and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrobenz [CD] indazoles, compositions and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1102468